TABLE 4.
Peptide | IFN-γ SFC frequency
|
|||
---|---|---|---|---|
Univariable regression
|
Multivariable regressiona
|
|||
Log10 plasma HIV-1 RNA | P | Log10 plasma HIV-1 RNA | P | |
HIV-1 | ||||
Env | 0.04 | 0.92 | 0.02 | 0.94 |
Gag | −0.36 | 0.21 | −0.32 | 0.21 |
Nef | −0.03 | 0.91 | −0.06 | 0.79 |
Tat | −0.22 | 0.63 | −0.04 | 0.93 |
Any HIV-1 peptide | −0.29 | 0.44 | 0.14 | 0.68 |
HIV-2 | ||||
Env | −0.59 | 0.15 | −0.34 | 0.38 |
Gag | −0.52 | 0.06 | −0.43 | 0.07 |
Nefb | NAc | NA | NA | NA |
Tat | 0.55 | 0.58 | 0.68 | 0.39 |
Any HIV-2 peptide | −0.50 | 0.09 | −0.33 | 0.19 |
Values were adjusted for CD4+ cell counts, study site, and gender.
None of the dually infected subjects had HIV-2 Nef responses.
NA, not applicable.